David A. Siegel Kamada LTD Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Kamada LTD stock. As of the latest transaction made, Two Sigma Advisers, LP holds 73,200 shares of KMDA stock, worth $492,636. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,200
Previous 16,632
340.12%
Holding current value
$492,636
Previous $109,000
420.18%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding KMDA
# of Institutions
42Shares Held
5.82MCall Options Held
21KPut Options Held
0-
Phoenix Holdings Ltd. Givatayim, L31.65MShares$11.1 Million0.17% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny832KShares$5.6 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA610KShares$4.11 Million0.0% of portfolio
-
Y.D. More Investments LTD Ramat Gan, L3330KShares$2.22 Million0.18% of portfolio
-
Essex Investment Management CO LLC Boston, MA324KShares$2.18 Million0.52% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $302M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...